Comments
Loading...
Stime degli utili, EPS e fatturato
Catalyst Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 5
Stima EPS
$0.346
Stima dei ricavi trimestrali
$138.56M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$558.50M
Analizza lo storico degli utili di Catalyst Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX | Catalyst Pharmaceuticals | $0.57 | $0.35 | — | — | $128.69M | $138.56M | — | — | 11/05/2025 | |
CPRX | Catalyst Pharmaceuticals | $0.56 | $0.38 | $0.68 | 23.64% | $122.71M | $140.42M | $146.56M | 4.73% | 08/06/2025 | |
CPRX | Catalyst Pharmaceuticals | $0.38 | $0.34 | $0.68 | 28.30% | $98.51M | $131.50M | $141.42M | 8.07% | 05/07/2025 | |
CPRX | Catalyst Pharmaceuticals | $0.53 | $0.34 | $0.70 | 27.27% | $110.57M | $134.20M | $141.81M | 5.67% | 02/26/2025 | |
CPRX | Catalyst Pharmaceuticals | $0.49 | $0.30 | $0.57 | 90.00% | $102.69M | $123.42M | $128.69M | 4.27% | 11/06/2024 | |
CPRX | Catalyst Pharmaceuticals | $0.53 | $0.26 | $0.56 | 115.38% | $99.58M | $111.87M | $122.71M | 9.60% | 08/07/2024 | |
CPRX | Catalyst Pharmaceuticals | $0.41 | $0.17 | $0.38 | 123.53% | $85.37M | $98.13M | $98.51M | 0.39% | 05/08/2024 | |
CPRX | Catalyst Pharmaceuticals | $0.31 | $0.26 | $0.53 | 103.85% | $60.76M | $106.12M | $110.57M | — | 02/28/2024 | |
CPRX | Catalyst Pharmaceuticals | $0.26 | $0.36 | $0.49 | 11.36% | $57.24M | $142.86M | $102.69M | 2.30% | 11/08/2023 | |
CPRX | Catalyst Pharmaceuticals | $0.28 | $0.36 | $0.53 | 26.19% | $53.11M | $141.34M | $99.58M | 7.39% | 08/09/2023 | |
CPRX | Catalyst Pharmaceuticals | $0.12 | $0.29 | $0.41 | 28.12% | $43.09M | $128.58M | $85.37M | 4.59% | 05/10/2023 | |
CPRX | Catalyst Pharmaceuticals | $0.09 | $0.34 | $0.31 | 47.62% | $38.31M | $134.12M | $60.76M | 4.59% | 03/15/2023 | |
CPRX | Catalyst Pharmaceuticals | $0.10 | $0.19 | $0.26 | 36.84% | $35.95M | $53.62M | $57.24M | 6.76% | 11/09/2022 | |
CPRX | Catalyst Pharmaceuticals | $0.11 | $0.17 | $0.28 | 64.71% | $36.37M | $49.21M | $53.11M | 7.93% | 08/09/2022 | |
CPRX | Catalyst Pharmaceuticals | $0.07 | $0.14 | $0.12 | -14.29% | $30.20M | $42.75M | $43.09M | 0.79% | 05/10/2022 | |
CPRX | Catalyst Pharmaceuticals | $0.11 | $0.12 | $0.09 | -25.00% | $31.02M | $38.19M | $38.31M | 0.31% | 03/16/2022 | |
CPRX | Catalyst Pharmaceuticals | $0.13 | $0.10 | $0.10 | 0.00% | $29.32M | $34.59M | $35.95M | 3.94% | 11/09/2021 | |
CPRX | Catalyst Pharmaceuticals | $0.09 | $0.09 | $0.11 | 22.22% | $29.61M | $31.51M | $36.37M | 15.41% | 08/09/2021 | |
CPRX | Catalyst Pharmaceuticals | $0.10 | $0.09 | $0.07 | -22.22% | $29.14M | $32.10M | $30.20M | -5.90% | 05/10/2021 | |
CPRX | Catalyst Pharmaceuticals | $0.07 | $0.09 | $0.11 | 22.22% | $30.12M | $30.35M | $31.02M | 2.19% | 03/15/2021 | |
CPRX | Catalyst Pharmaceuticals | $0.13 | $0.10 | $0.13 | 30.00% | $30.90M | $31.49M | $29.32M | -6.90% | 11/09/2020 |
Catalyst Pharmaceuticals (CPRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $0.68 | $0.38 | 23.6 % |
| Q1 | 2025-05-07 | $0.68 | $0.34 | 28.3 % |
| Q4 | 2025-02-26 | $0.70 | $0.34 | 27.3 % |
| Q3 | 2024-11-06 | $0.57 | $0.30 | 90.0 % |
Catalyst Pharmaceuticals (CPRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $146.56M | $140.42M | 4.73 % |
| Q1 | 2025-05-07 | $141.42M | $131.50M | 8.07 % |
| Q4 | 2025-02-26 | $141.81M | $134.20M | 5.67 % |
| Q3 | 2024-11-06 | $128.70M | $123.42M | 4.27 % |
FAQ
Quando Catalyst Pharmaceuticals (NASDAQ:CPRX) riporterà gli utili?
Si prevede che Catalyst Pharmaceuticals (CPRX) fornisca risultati il novembre 5, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Catalyst Pharmaceuticals (NASDAQ:CPRX)?
L'EPS effettivo era $0.68, che superato la stima di $0.38.
Quali sono state le entrate di Catalyst Pharmaceuticals (NASDAQ:CPRX)?
Le entrate effettive sono state $146.6M, che superato la stima di $140.4M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.